MedPath

OLYMPUS CORPORATION

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Not Applicable
Terminated
Conditions
Emphysema
Interventions
Device: OL-BF-001
First Posted Date
2015-06-12
Last Posted Date
2019-08-28
Lead Sponsor
Olympus Corporation
Target Recruit Count
38
Registration Number
NCT02470052

Spectroscopy From Duodenum

Not Applicable
Completed
Conditions
Pancreatic Adenocarcinoma
Interventions
Other: Spectroscopy device
First Posted Date
2012-12-20
Last Posted Date
2017-03-07
Lead Sponsor
Olympus Corporation
Target Recruit Count
445
Registration Number
NCT01753479
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

🇧🇪

Hôpital Erasme, Bruxelles, Brussels-Capital Region, Belgium

🇺🇸

Mayo Clinic Florida, Jacksonville, Florida, United States

and more 1 locations

Pancreatic Juice Diagnosis From Duodenum

Not Applicable
Completed
Conditions
Pancreatic Adenocarcinoma
Interventions
Other: Tumor markers
First Posted Date
2012-10-04
Last Posted Date
2015-09-21
Lead Sponsor
Olympus Corporation
Target Recruit Count
105
Registration Number
NCT01699698
Locations
🇺🇸

Mayo Clinic Jacksonville, Jacksonville, Florida, United States

🇯🇵

Kyushu University, Fukuoka-shi, Fukuoka-ken, Japan

© Copyright 2025. All Rights Reserved by MedPath